DexCom Reports First Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended March 31, 2013.
Product revenue grew to $27.8 million for the first quarter of 2013, an increase of approximately 49% from the $18.6 million in product revenue reported for the first quarter of 2012. Total first quarter 2013 revenue, which included development grant and other revenue, grew to $29.6 million, an increase of 47% from the same quarter in 2012.
Help employers find you! Check out all the jobs and post your resume.
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended March 31, 2013.
Product revenue grew to $27.8 million for the first quarter of 2013, an increase of approximately 49% from the $18.6 million in product revenue reported for the first quarter of 2012. Total first quarter 2013 revenue, which included development grant and other revenue, grew to $29.6 million, an increase of 47% from the same quarter in 2012.
Help employers find you! Check out all the jobs and post your resume.